Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.49% | 331.97 | 0.0% | $4431.16m | |
| BNTX | BioNTech SE | 2.15% | 268.50 | 0.0% | $738.75m | |
| NVAX | Novavax, Inc. | -15.16% | 136.21 | 79.4% | $603.27m | |
| AMGN | Amgen, Inc. | 1.57% | 210.04 | 1.4% | $554.93m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 4.56% | 6.42 | 0.7% | $448.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.70% | 561.50 | 2.7% | $438.92m | |
| GILD | Gilead Sciences, Inc. | 0.37% | 67.15 | 1.0% | $414.60m | |
| CCXI | ChemoCentryx, Inc. | 2.82% | 34.60 | 2.9% | $396.23m | |
| ILMN | Illumina, Inc. | -0.10% | 413.65 | 3.3% | $374.23m | |
| XLRN | Acceleron Pharma, Inc. | -0.43% | 173.00 | 5.3% | $348.83m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.39% | 186.13 | 1.9% | $270.81m | |
| BIIB | Biogen, Inc. | -0.52% | 266.75 | 1.7% | $242.28m | |
| OCGN | Ocugen, Inc. | 4.20% | 8.68 | 0.0% | $183.83m | |
| XENE | Xenon Pharmaceuticals, Inc. | 2.01% | 30.41 | 0.4% | $163.60m | |
| CRSP | CRISPR Therapeutics AG | -1.49% | 98.77 | 0.6% | $159.71m |
Company Profile
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. The firm operates through the Biopharmaceuticals and Bioprocessing segments. The company was founded by Robert B. Kay on April 15, 1993 and is headquartered in Bryan, TX.